参芪扶正汤治疗Ⅲ~Ⅳ期胃癌临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R735.2;R273

基金项目:


Clinical Study on Shenqi Fuzheng Tang for Gastric Cancer in Stage III to IV
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨参芪扶正汤对Ⅲ~Ⅳ期胃癌患者免疫功能、细胞因子水平及生活质量的影响。方法:选取 86 例Ⅲ~Ⅳ期胃癌患者,按随机数字表法分为对照组和观察组各 43 例。对照组采用 XELOX 化疗方案,观察组在对照组基础上加用参芪扶正汤。比较 2 组治疗前后的免疫功能、细胞因子水平、生活质量及化疗毒性反应发生情况。结果:治疗前,2 组 CD3+、CD4+、CD8+、CD4+/CD8+比较,差异无统计学意义(P>0.05)。治疗后,观察组 CD3+、CD4+、CD4+/CD8+高于治疗前及对照组(P<0.05)。治疗前,2 组可溶性白细胞介素-2 受体 (SIL-2R)、白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α) 水平比较,差异无统计学意义 (P>0.05)。治疗后,2 组 SIL-2R、IL-6 及 TNF-α 水平均较治疗前降低 (P<0.05),且观察组 SIL-2R、IL-6 及 TNF-α水平均低于对照组 (P<0.05)。治疗前,2 组癌症患者生活质量测定量表 (QOL) 评分比较,差异无统计学意义 (P>0.05)。治疗后,观察组 QOL 评分高于治疗前及对照组(P<0.05),而对照组 QOL 评分低于治疗前(P<0.05)。治疗期间,观察组化疗毒性反应明显轻于对照组,差异有统计学意义(Z=-5.049,P=0.000)。结论:参芪扶正汤能明显改善Ⅲ~Ⅳ期胃癌患者的免疫功能和细胞因子水平,减轻化疗毒性反应,提高生活质量。

    Abstract:

    Abstract:Objective:To study the effect of Shenqi Fuzheng tang on the immune function,the levels of cytokines and the quality of life in patients with gastric cancer in stage III to IV. Methods:A total of 86 cases of patients with gastric cancer in stage III to IV were selected and divided into the control group and the observation group according to the random number table method,43 cases in each group. The control group was treated with XELOX chemotherapy and the observation group was additionally treated with Shenqi Fuzheng tang based on the treatment of the control group. Before and after treatment, the immune function,the levels of cytokines,the quality of life and the incidence of chemotherapeutic toxic reactions in the two groups were compared. Results:Before treatment,there was no significant difference being found in the comparison of CD3+,CD4+,CD8+ and CD4+/CD8+ between the two groups(P>0.05). After treatment,CD3+,CD4+ and CD4+/CD8+ in the observation group were higher than those before treatment and those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of soluble interleukin- 2 receptor(SIL- 2R), interleukin-6(IL-6) and tumor necrosis factor α(TNF-α) between the two groups(P>0.05). After treatment,the levels of SIL-2R,IL-6 and TNF-α in the two groups were decreased when compared with those before treatment(P<0.05),and the above levels in the observation group were lower than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the scores of Quality of Life Scale(QOL) between the two groups (P>0.05). After treatment,the QOL score in the observation group was higher than that before treatment and that in the control group(P<0.05),and the QOL score in the control group was lower than that before treatment(P<0.05). During the treatment,the chemotherapeutic toxic reactions in the observation group were significantly fewer than those in the control group,the difference being significant(Z=-5.049,P=0.000). Conclusion:Shenqi Fuzheng tang can obviously improve the immune function and the levels of cytokines in patients with gastric cancer in stage III to IV,reduce the chemotherapeutic toxic reactions and enhance the quality of life.

    参考文献
    相似文献
    引证文献
引用本文

毛跃峰,爨国庆,李彩霞.参芪扶正汤治疗Ⅲ~Ⅳ期胃癌临床研究[J].新中医,2020,52(24):112-114

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-12-22
  • 出版日期: